share_log

康辰药业:北京国枫律师事务所关于北京康辰药业股份有限公司2023年限制性股票激励计划回购注销部分限制性股票的法律意见书

Kangchen Pharmaceutical: Legal Opinion of Beijing Guofeng Law Firm on the 2023 Restricted Stock Incentive Plan of Beijing Kangchen Pharmaceutical Co., Ltd. to repurchase and cancel some restricted stocks

SZSI ·  Sep 30
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more